SCHEDULE 13G/A: Janus Henderson Group PLC Discloses 3.0% Passive Stake in Immunic, Inc.
Beneficial Ownership Disclosure
Janus Henderson Group PLC has filed an amended Schedule 13G, reporting a 3.0% beneficial ownership stake in Immunic, Inc. as of December 31, 2024, held for investment purposes in the ordinary course of business.
Summary
- Janus Henderson Group PLC, a Jersey-based entity, reported beneficial ownership of 2,689,082 shares of Immunic, Inc. common stock.
- This represents 3.0% of Immunic, Inc.'s outstanding common stock.
- The shares are held with shared voting power and shared dispositive power.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Immunic, Inc.
- The beneficial ownership is attributed to Janus Henderson Group PLC and its indirect subsidiaries, JHIUS, JHIUKL, and JHIAIFML, which are registered investment advisers furnishing investment advice to Managed Portfolios.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of passive beneficial ownership, indicating a neutral sentiment as it does not suggest any active intent to influence or change control of the issuer.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of passive beneficial ownership by an institutional investor and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's passive stake, which may offer some confidence in the stock's liquidity and institutional interest.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of execution of the Power of Attorney by Janus Henderson Group plc. |
| 2024-12-31 | Date of event which requires the filing of this statement, representing the reporting period end for beneficial ownership. |
| 2025-02-14 | Date the Schedule 13G Amendment No. 2 was signed by Janus Henderson Group PLC. |
Keywords
Immunic Inc, Janus Henderson Group PLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.